General Home Investors News

MedinCell signs a licence agreement with the Medicines Patent Pool to fight malaria transmission, as part of its global health mission

By MedincellSeptember 13, 2022March 15th, 2024No Comments

MedinCell signs a licence agreement with the Medicines Patent Pool to fight malaria transmission, as part of its global health mission

September 13, 2022

Previous PostMedinCell’s partner Teva today announced refiling for approval of mdc-IRM and confirmed planned launch in the U.S. in H1 2023
Next PostMedinCell releases the results of its September 8, 2022 ordinary annual and extraordinary general meeting

Better medicine for all

Website by ScreenUp